Literature DB >> 31522619

Superiority of Out-of-Office Blood Pressure for Predicting Hypertensive Heart Disease in Non-Hispanic Black Adults.

Florian Rader1, Stanley S Franklin2, James Mirocha3, Wanpen Vongpatanasin4, Robert W Haley5, Ronald G Victor1.   

Abstract

Black Americans suffer disproportionately from hypertension and hypertensive heart disease. Out-of-office blood pressure (BP) is more predictive for cardiovascular complications than clinic BP; however, the relative abilities of clinic and out-of-office BP to predict left ventricular hypertrophy in black and white adults have not been established. Thus, we aimed to compare associations of out-of-office and clinic BP measurement with left ventricular hypertrophy by cardiac magnetic resonance imaging among non-Hispanic black and white adults. In this cross-sectional study, 1262 black and 927 white participants of the Dallas Heart Study ages 30 to 64 years underwent assessment of standardized clinic and out-of-office (research staff-obtained) BP and left ventricular mass index. In multivariable-adjusted analyses of treated and untreated participants, out-of-office BP was a stronger determinant of left ventricular hypertrophy than clinic BP (odds ratio per 10 mm Hg, 1.48; 95% CI, 1.34-1.64 for out-of-office systolic BP and 1.15 [1.04-1.28] for clinic systolic BP; 1.71 [1.43-2.05] for out-of-office diastolic BP, and 1.03 [0.86-1.24] for clinic diastolic BP). Non-Hispanic black race/ethnicity, treatment status, and lower left ventricular ejection fraction were also independent determinants of hypertrophy. Among treated Blacks, the differential association between out-of-office and clinic BP with hypertrophy was more pronounced than in treated white or untreated participants. In conclusion, protocol-driven supervised out-of-office BP monitoring provides important information that cannot be gleaned from clinic BP assessment alone. Our results underscore the importance of hypertension management programs outside the medical office to prevent hypertensive heart disease, especially in high-risk black adults. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT00344903.

Entities:  

Keywords:  blood pressure monitoring; cross-sectional study; hypertension; hypertrophy; magnetic resonance imaging

Mesh:

Substances:

Year:  2019        PMID: 31522619      PMCID: PMC6785391          DOI: 10.1161/HYPERTENSIONAHA.119.13542

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  49 in total

1.  Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators.

Authors:  J A Staessen; G Byttebier; F Buntinx; H Celis; E T O'Brien; R Fagard
Journal:  JAMA       Date:  1997-10-01       Impact factor: 56.272

Review 2.  White-coat hypertension: new insights from recent studies.

Authors:  Stanley S Franklin; Lutgarde Thijs; Tine W Hansen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2013-09-16       Impact factor: 10.190

3.  Management of hypertension: summary of NICE guidance.

Authors:  Taryn Krause; Kate Lovibond; Mark Caulfield; Terry McCormack; Bryan Williams
Journal:  BMJ       Date:  2011-08-25

4.  Target organ complications and prognostic significance of alerting reaction: analysis from the Dallas Heart Study.

Authors:  Alejandro Velasco; Colby Ayers; Sandeep R Das; James A de Lemos; Amit Khera; Ronald G Victor; Norman M Kaplan; Wanpen Vongpatanasin
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

5.  Racial/ethnic differences in the prognostic utility of left ventricular mass index for incident cardiovascular disease.

Authors:  Emmanuel Akintoye; Karim Mahmoud; Mohamed Shokr; Aubin Sandio; Sagar Mallikethi-Reddy; Muhammad Sheikh; Oluwole Adegbala; Alexander Egbe; Alexandros Briasoulis; Luis Afonso
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

6.  Prevalence of Masked Hypertension Among US Adults With Nonelevated Clinic Blood Pressure.

Authors:  Y Claire Wang; Daichi Shimbo; Paul Muntner; Andrew E Moran; Lawrence R Krakoff; Joseph E Schwartz
Journal:  Am J Epidemiol       Date:  2017-02-01       Impact factor: 4.897

Review 7.  Blood Pressure Monitoring. Task force V: White-coat hypertension.

Authors:  T G Pickering; A Coats; J M Mallion; G Mancia; P Verdecchia
Journal:  Blood Press Monit       Date:  1999-12       Impact factor: 1.444

8.  Do community based self-reading sphygmomanometers improve detection of hypertension? A feasibility study.

Authors:  William Hamilton; Alison Round; Rebecca Goodchild; Cindy Baker
Journal:  J Public Health Med       Date:  2003-06

Review 9.  Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population.

Authors:  Stanley S Franklin; Lutgarde Thijs; Tine W Hansen; Yan Li; José Boggia; Masahiro Kikuya; Kristina Björklund-Bodegård; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2012-01-17       Impact factor: 10.190

10.  Impact of 2017 ACC/AHA hypertension guidelines on the prevalence of white-coat and masked hypertension: A home blood pressure monitoring study.

Authors:  Audes D M Feitosa; Marco A Mota-Gomes; Roberto D Miranda; Weimar S Barroso; Eduardo C D Barbosa; Rodrigo P Pedrosa; Paula C Oliveira; Camila L D M Feitosa; José L Lima-Filho; Andrei C Sposito; Wilson Nadruz
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-30       Impact factor: 3.738

View more
  1 in total

1.  Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-Reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT).

Authors:  Shreya Rao; Matthew W Segar; Adam P Bress; Pankaj Arora; Wanpen Vongpatanasin; Vijay Agusala; Utibe R Essien; Adolfo Correa; Alanna A Morris; James A de Lemos; Ambarish Pandey
Journal:  JAMA Cardiol       Date:  2020-11-13       Impact factor: 14.676

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.